Importantly, the reaction to MYSTIC might be overly strong, and we'll take a look at why.
Last week, AZN announced top-line data from their phase 3 MYSTIC study, which was a randomized study with three treatment arms: durvalumab alone, durvalumab plus tremelimumab, and chemotherapy.AZN durvalumab inhibitor line MYSTIC Pacific patients PD PD L1 tumor
Acorda Therapeutics (ACOR) is a $1 billion market cap company focused on developing inhalation therapies to improve the lives of those afflicted with neurological disorders.
Acorda's lead candidate, CVT-301 (INBRIJA), met its primary endpoint showing statistically significant improvement of motor function compared to placebo in its phase 3 SPAN-PD clinical trial for Parkinson's disease (PD).ACOR candidate CVT development drug Inbrija market PD Phase treatment
The premier event for biotech and pharma companies in 2017 is just around the corner.
Here, 24/7 Wall St. is specifically taking a look at Merck & Co. Inc. (NYSE: MRK) and what Credit Suisse sees happening for this pharma giant at ASCO.abstract ASCO cancer combination Incyte June Keytruda Merck PD perspective
Shares of Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) saw a huge gain on Wednesday after the firm gave an update on its non-small cell lung cancer (NSCLC) midstage trial. Specifically, the company announced that Encore 601 has met the prespecified objective response threshold to advance into the second stage of the Phase 2 trial and will reopen enrollment immediately.enrollment L1 NSCLC objective patients PD previously response therapy trial
The Financial Times reports on the Rebellion that Threatens to Split Italy’s Democratic Party.
The immediate impact would be a loss of 6 percentage points, or more, support for PD, putting Beppe Grillo’s Five Star Movement solidly in the lead.Bersani Corriere dissidents Italian left Mr party PD Rebel Renzi
An analysis of the political setup in Italy shows eurosceptics are on the verge of taking control of the country.
Former prime minister Matteo Renzi stepped down in December after holding a referendum that failed miserably.early election electoral Grillo Italian movement parliament party PD Renzi star